Webinars

DIAD family webinars about DIAN-TU research are offered twice a year, in English. Also, there may be occasional webinars addressing other topics. You may register to participate in the next webinar or view past webinars at your convenience below.

Archived webinars

To access information from past DIAD family webinars in English, click on the links below.

  • New!! Webinar with Dr. Randall Bateman on May 4, 2024, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a former OLE participant or a family member of a former OLE participant.
  • New!! Webinar with Dr. Eric McDade on May 4, 2024, on the Primary Prevention Trial. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Question and answer session with Dr. Randall Bateman on December 16, 2023, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a former OLE participant or a family member of a former OLE participant.
  • Question and answer session with Dr. Randall Bateman on August 14, 2023, on the ending of the open-label extension trial with gantenerumab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are an OLE participant or a family member of an OLE participant.
  • Audio presentation with Dr. Randall Bateman on April 29, 2023, on the open-label extension trial with gantenerumab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are an OLE participant or a family member of an OLE participant.
  • Question and answer session with Dr. Eric McDade on December 21, 2022, on the Primary Prevention Clinical trial. This recording  is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Slides and audio presentation from November 19, 2022, on gantenerumab. This recording  is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Question and answer session with Dr. Randall Bateman and Dr. Eric McDade on September 30, 2022, on lecanemab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Slides and audio presentation from May 14, 2022. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Slides and audio presentation from November 20, 2021. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease. In response to information shared on this webinar, a memo from Dr. Bateman and Dr. McDade seeks to clarify reasons for new eligibility criteria for the Tau NexGen clinical trial.
  • Slides and audio presentation from June 25, 2021 on approval of aducanumab. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.
  • Slides and audio presentation from April 17, 2021. This recording is password protected. Please email dianexr@wustl.edu to request the password if you are a member of a family living with dominantly-inherited Alzheimer’s disease.

Participant webinar streamed live on January 25th, 2017